(2 years, 1 month ago)
Commons ChamberThe Bill is setting the immediate support, which will run until April. The Government are reviewing how to ensure that support is more targeted in future, but there is no question that there will be support, and the Bill provides the powers for that. It is important to emphasise that bills will still depend on usage. That is why I am grateful for the work of my hon. Friend the Member for Hexham (Guy Opperman), who has emphasised the advantages of a prudent use of energy benefiting all users.
The Secretary of State talks about energy usage and families not having bills of more than £2,500, but bills for large families with high usage will be far, far more. How can families have certainty? If the Government will not have a communications campaign on reducing energy usage—they have said that they are against that on principle—how do we get that message across to people up and down the country?
What we are doing is making it clear that it will depend on usage and that the figures are average figures. The £2,500, therefore, is for an average family and, obviously, not necessarily for all families. Larger families will have particular pressures, but I am coming on to the other support that remains which will help families. The price per unit of electricity and gas is part of the package, but it is of course combined, and we recognise the difficulties that families and businesses will face with higher prices.
(3 years, 5 months ago)
Commons ChamberThe Climate Change Committee’s annual report published today is stark. It mentions serious gaps in policy and strategy, lack of detail around key areas such as planning, decarbonisation of homes, oil and gas and even failing to produce a net zero strategy in the year that we host COP. This is a Government who are quick to promise but fail at every turn to deliver, and the longer that they delay, the more severe and irreversible the damage becomes and the more likely it is that we suffer serious drought, heatwaves and floods, with the immense impact that has on people and livelihoods. To ensure that climate action is at the heart of all policies and all Departments, will the Leader of the House agree to allowing for far more time for this Parliament to debate the report and to scrutinise and properly hold this failing Government to account?
As I said earlier, I am not interested in eating less meat; I want to eat more meat and I want my constituents to be able to as well. The Government’s record since 2010 is formidable. They have reduced greenhouse gas emissions by 26% between 2010 and 2019. Renewable electricity generation has more than quadrupled since 2010. The year 2019 was the cleanest on record with more than half of UK electricity coming from low-carbon technologies. As I said earlier, we have cut emissions by 43% since 1990, with 75% economic growth. We are targeting a reduction in emissions by 78% by 2035 compared with 1990 levels. We are on the right path to net zero by 2050, but we have to do this with economic growth. We are not fanatics; we are sensible and proportionate in what we are trying to do and we have been doing it with considerable success since 2010.
(3 years, 10 months ago)
Commons ChamberMay I say how much I sympathise with my hon. Friend? Just before I entered Government, I had a case of a young child who needed a very expensive and unusual drug, and I am very glad to say that, in the end, that child got it. I encourage my hon. Friend to use every parliamentary mechanism he can possibly think of to campaign for this child. It is so important that we help our young constituents, who have long lives ahead of them.
Such issues are decided by the National Institute for Health and Care Excellence, which is the independent body responsible for providing evidence-based guidance for the NHS on whether medicines represent a clinical and cost-effective use of resources. The NHS in England is legally required to fund medicines recommended through a NICE appraisal, usually within three months of final guidance. NICE is currently appraising Kuvan for PKU and aims to publish its recommendation in April. My hon. Friend may also wish to be aware that applications for generic versions of the drug may now be submitted.
Following the UK’s exit from the European Union, the Medicines and Healthcare Products Regulatory Agency is the UK’s stand-alone medicines regulator and has introduced an accelerated national assessment procedure. That is open to applications for generic medicines, as well as innovative medicines, and in a timeframe to reach a licensing decision in 150 days rather than the 200-day EU procedure. However, I have such sympathy with my hon. Friend and with the child and family in question, and I encourage him to keep knocking on everybody’s door.
I add my congratulations to President Biden and Vice-President Harris on their historic inauguration. Last week, the former US President Trump imposed deliberately stringent sanctions on the Houthis in Yemen that cannot easily be undone. Far from targeting individuals involved in acts of terror, this decision is a death sentence for millions who will now be cut off from life-saving aid in what is already the world’s gravest humanitarian emergency. Despite that, the Government have shown no leadership on this crucial issue, with no official response from the Foreign Secretary, and I am yet to receive a reply to my letter from 11 December. Can the Leader of the House please grant time for an urgent update on this critical matter?
I have always said that I will try to achieve speedy replies for Members when they ask for them, and I will certainly take this up with the Foreign Secretary to get a response to the hon. Lady’s letter. The UK Government have been doing what they can in Yemen, both with funding and through diplomacy, to try to make a very, very difficult and sad situation better, but she is obviously right to try to seek further answers from the Foreign Office.